Venture Capital Investors

F-Prime Capital

F-Prime Capital is focused on investing in companies focused on high-impact, technology-driven solutions.

Venture Investor Overview

Venture Investor
F-Prime Capital
Status
Active
Investor Type
Venture Capital
Activity Level
295 transactions
Funds Raised
Unknown
Industry Focus
Advanced Materials
Artificial Intelligence
Biopharmaceutical
Blockchain
Digital Media & VR & AR
EdTech
Enterprise IT
FinTech
Healthcare IT
Healthcare Services
HRTech
InsureTech
Internet & IoT
Life Sciences
Manufacturing
Medical Devices & Instruments
Mobile
Real Estate
Robotics
Software
Transportation

Contact Information

Contact
Stephen Knight
Title
Managing Partner
Mailing Address
1 Main St. 13th Floor
Cambridge, MA 02142
USA
Phone
(617) 231-2400
Website
www.fprimecapital.com
Email Address
[email protected]

Background Information

Overview
F-Prime Capital is a global venture capital firm investing in life sciences, healthcare and technology. Since 1969, F-Prime has worked closely with entrepreneurs and academics to create innovative solutions to some of the world's most significant challenges in healthcare and technology.
Profile
F-Prime Capital LinkedIn Company Profile
Social Media
F-Prime Capital Company Twitter Account
Company News
F-Prime Capital News
Facebook
F-Prime Capital on Facebook
YouTube
F-Prime Capital on YouTube
Last Transaction
4/17/2024

Transaction History

Our records indicate that F-Prime Capital invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Toku
4/17/2024
$9,300,000
Engrail Therapeutics
3/19/2024
$157,000,000
HiLabs
3/14/2024
$39,000,000
OneAdvisory
1/11/2024
$8,000,000
Burro
1/9/2024
$24,000,000
Devoted Health
12/29/2023
$175,000,000
Shinobi Therapeutics
12/12/2023
$51,000,000
ARTBIO
12/7/2023
$90,000,000
T-Therapeutics
11/16/2023
$59,794,000
Eleos Health
11/9/2023
$40,000,000
Avalyn Pharma
9/27/2023
$175,000,000
Doceree
9/27/2023
$35,000,000
Adela
9/26/2023
$48,000,000
Better Life Partners
8/28/2023
$26,500,000
Simon Data
8/8/2023
$54,000,000
Tenpoint Therapeutics
7/13/2023
$70,000,000
Albert Invent
6/14/2023
$7,500,000
BenchSci
5/25/2023
$70,000,000
Cadence Neuroscience
5/17/2023
$26,000,000
Axoni
4/26/2023
$20,000,000
Tradier
4/13/2023
Unknown
1upHealth
4/12/2023
$40,000,000
Toku
3/23/2023
$7,150,000
SpectrumAi
3/16/2023
$20,000,000
Zus Health
3/16/2023
$40,000,000
Bicara Therapeutics
3/6/2023
$108,000,000
TandemAI
3/1/2023
$35,000,000
Canoe Intelligence
2/8/2023
$25,000,000
nOCD
1/31/2023
$34,000,000
Paradigm
1/31/2023
$203,000,000
Ensoma
1/10/2023
$85,000,000
Pulmocide
12/6/2022
$52,000,000
ABK Biomedical
12/6/2022
$30,000,000
Deal Engine
11/15/2022
$5,300,000
Canary Technologies
10/27/2022
$30,000,000
Neumora Therapeutics
10/11/2022
$112,000,000
Rippl Care
9/28/2022
$32,000,000
Elucidata
9/27/2022
$16,000,000
Ashby
9/13/2022
$21,500,000
Hone
9/13/2022
$30,000,000
Sironax
8/2/2022
$200,000,000
Latchel
7/27/2022
$16,700,000
Vendr
6/16/2022
$150,000,000
Proximie
6/14/2022
$80,000,000
Charm Therapeutics
6/10/2022
$50,000,000
Peptone
6/9/2022
$40,000,000
Teleo
6/8/2022
$12,000,000
SpectrumAi
6/2/2022
$9,000,000
Mathison
5/12/2022
$25,000,000
Invetx
5/10/2022
$60,500,000
Doceree
4/7/2022
$11,000,000
Eleos Health
4/5/2022
$20,000,000
AmplifyMD
3/28/2022
$23,000,000
RightHand Robotics
3/15/2022
$66,000,000
Silq
3/9/2022
$17,600,000
Rialtic
3/2/2022
$45,000,000
Equip
2/28/2022
$58,000,000
Canary Technologies
2/24/2022
$15,000,000
Expressable
2/24/2022
$15,000,000
Logixboard
2/2/2022
$32,000,000
Leyden Labs
2/2/2022
$140,000,000
Parrot
1/11/2022
$9,500,000
Papaya Payments
12/16/2021
$50,000,000
K36 Therapeutics
12/10/2021
$30,000,000
OTA Insight
11/19/2021
$80,000,000
AppliedVR
11/12/2021
$36,000,000
Notabene
11/10/2021
$10,200,000
Notable Health
11/4/2021
$100,000,000
Hone
11/3/2021
$16,000,000
Stride Health
10/27/2021
$47,000,000
Funnel AB
10/14/2021
$66,000,000
Burro
9/29/2021
$10,900,000
Centivo
9/23/2021
$51,000,000
nOCD
9/22/2021
$33,000,000
RareCyte
9/13/2021
$24,000,000
Carrot Fertility
8/19/2021
$75,000,000
Innovusion
8/17/2021
$66,000,000
MoEngage
8/3/2021
$32,500,000
SonderMind
7/29/2021
$150,000,000
Embark Veterinary
7/27/2021
$75,000,000
Turnstone Biologics
7/22/2021
$80,000,000
Vestwell
7/21/2021
$70,000,000
Castor Research
7/15/2021
$45,000,000
Prime Medicine
7/14/2021
$200,000,000
Adela
6/24/2021
$60,000,000
Zus Health
6/18/2021
$34,000,000
Protenus
6/16/2021
$21,000,000
Zenflow
6/3/2021
$24,000,000
Snapdocs
5/26/2021
$150,000,000
Innovusion
5/10/2021
$64,000,000
Affinia Therapeutics
5/4/2021
$110,000,000
1upHealth
4/30/2021
$25,000,000
Logixboard
4/29/2021
$13,000,000
Firefly Health
4/8/2021
$40,000,000
AppliedVR
3/25/2021
$29,000,000
Leyden Labs
3/25/2021
$47,000,000
Vendr
3/9/2021
$60,000,000
Ensoma
2/12/2021
$70,000,000
Equip
2/11/2021
$13,000,000
Hurdle
1/26/2021
$5,000,000
Atalanta Therapeutics
1/12/2021
$110,000,000
Centivo
12/8/2020
$34,000,000
ConnexPay
12/3/2020
$8,000,000
Odaseva
10/29/2020
$25,000,000
Argyle
10/16/2020
$20,000,000
Snapdocs
10/13/2020
$60,000,000
Carrot Fertility
8/19/2020
$24,000,000
Sana Biotechnology
6/29/2020
$700,000,000
Verve Therapeutics
6/12/2020
$63,000,000
Checkmate Pharmaceuticals
6/11/2020
$85,000,000
PatientPing
6/10/2020
$60,000,000
NFlection Therapeutics
6/10/2020
$20,000,000
Rallybio
5/20/2020
$145,000,000
OWKIN
5/8/2020
$25,000,000
Avalyn Pharma
4/29/2020
$35,500,000
SonderMind
4/7/2020
$27,000,000
Affinia Therapeutics
4/1/2020
$60,000,000
Xilio Therapeutics
3/3/2020
$100,500,000
Whatfix
2/20/2020
$32,000,000
MoEngage
2/12/2020
$25,000,000
Iora Health
2/11/2020
$126,000,000
BenchSci
2/5/2020
$22,000,000
Wellframe
11/20/2019
$20,000,000
Snapdocs
11/11/2019
$25,000,000
Vendr
10/24/2019
$2,000,000
Logixboard
10/23/2019
$4,200,000
Recurly
10/3/2019
$19,500,000
AvantStay
9/19/2019
$20,000,000
Firefly Health
9/17/2019
$10,200,000
InSilico Medicine
9/16/2019
$37,000,000
EVEN Financial
9/6/2019
$25,500,000
Protenus
8/21/2019
$17,000,000
Simon Data
8/20/2019
$30,000,000
Quartet
6/18/2019
$60,000,000
Snapsheet
5/21/2019
$29,000,000
LunaPBC
5/9/2019
$4,600,000
Verve Therapeutics
5/8/2019
$58,500,000
Nocion Therapeutics
4/19/2019
$27,000,000
Embark Veterinary
4/12/2019
$10,000,000
ABK Biomedical
4/10/2019
$30,000,000
RiskLens
4/9/2019
$20,550,000
Vestwell
4/3/2019
$30,000,000
Artemis Health
3/16/2019
$25,000,000
Whatfix
3/14/2019
$12,500,000
OWKIN
3/8/2019
Unknown
Beam Therapeutics
3/7/2019
$135,000,000
Castle Security
2/11/2019
$9,200,000
AvantStay
12/20/2018
$5,000,000
Innovusion
10/26/2018
$30,000,000
Modis Therapeutics
10/2/2018
$30,000,000
Xilio Therapeutics
9/28/2018
$30,000,000
CareStack
9/24/2018
$16,000,000
Notable Health
9/7/2018
$13,500,000
Nebula Genomics
8/30/2018
$4,300,000
TraceLink
8/22/2018
$93,000,000
Axoni
8/15/2018
$32,000,000
EVEN Financial
8/8/2018
$18,800,000
RiskRecon
8/8/2018
$25,000,000
Simon Data
7/31/2018
$20,000,000
Flywire
7/27/2018
$100,000,000
Centivo
7/19/2018
$34,000,000
Compass Therapeutics
7/13/2018
$49,000,000
WelbeHealth
6/30/2018
$15,000,000
Precision BioSciences
6/27/2018
$110,000,000
Unison Home Ownership Investors
6/27/2018
$40,000,000
Benchling
6/15/2018
$14,500,000
Iora Health
5/22/2018
$100,000,000
Beam Therapeutics
5/15/2018
$87,000,000
Tempest Therapeutics
3/29/2018
$70,000,000
Zenflow
2/8/2018
$31,400,000
Protenus
1/23/2018
$11,000,000
Quartet
1/5/2018
$40,000,000
OTA Insight
12/14/2017
$20,000,000
Semma Therapeutics
12/1/2017
$114,000,000
Vestwell
10/3/2017
$8,000,000
Threat Stack
9/20/2017
$45,000,000
Stride Health
8/23/2017
$23,500,000
Artemis Health
8/17/2017
$16,000,000
Apellis Pharmaceuticals
8/11/2017
$60,000,000
Buoy Health
8/10/2017
$6,700,000
Amphora Medical
7/21/2017
$35,500,000
Protenus
7/20/2017
$3,000,000
Menlo Therapeutics
7/19/2017
$50,000,000
Wellframe
7/13/2017
$15,000,000
Checkmate Pharmaceuticals
6/17/2017
$27,000,000
RiskRecon
6/2/2017
$12,000,000
blispay
5/24/2017
$12,000,000
Genoa Pharmaceuticals
5/16/2017
$62,000,000
Axoni
5/12/2017
$2,000,000
Quovo
4/27/2017
$10,000,000
Promentis Pharmaceuticals
3/31/2017
$26,000,000
Pulmocide
3/22/2017
$30,000,000
WelbeHealth
2/9/2017
$15,000,000
Avidity Biosciences
1/6/2017
$16,000,000
TraceLink
12/1/2016
$51,500,000
Castle Security
11/10/2016
$2,000,000
Turnstone Biologics
11/3/2016
$41,400,000
Snapsheet
10/18/2016
$20,000,000
Iora Health
10/14/2016
$75,000,000
Akriveia Therapeutics
10/13/2016
$7,500,000
Compass Therapeutics
9/30/2016
$28,312,000
Vestwell
9/21/2016
$4,500,000
Caribou Biosciences
5/16/2016
$30,000,000
Quartet
4/14/2016
$40,000,000
US HealthVest
3/31/2016
$59,000,000
Iowa Approach
3/31/2016
$15,000,000
VitalWare
2/29/2016
Unknown
Adagene
1/29/2016
$28,000,000
PatientPing
11/16/2015
$9,600,000
Kyruus
9/17/2015
$25,000,000
Proteostasis Therapeutics
9/9/2015
$37,000,000
US HealthVest
6/30/2015
$10,000,000
Unum Therapeutics
6/11/2015
$65,000,000
PAX Labs
6/11/2015
$46,700,000
Stride Health
5/20/2015
$13,000,000
REGENXBIO
5/20/2015
$70,500,000
Denali Therapeutics
5/15/2015
$217,000,000
Symbiomix Therapeutics
5/6/2015
$41,000,000
Dimension Therapeutics
4/21/2015
$65,000,000
Caribou Biosciences
4/3/2015
$11,000,000
Quartet
4/3/2015
$7,000,000
Semma Therapeutics
3/25/2015
$44,000,000
Mersana Therapeutics
3/2/2015
$35,000,000
TraceLink
2/18/2015
$20,000,000
Surface Oncology
1/9/2015
$35,000,000
Adagene
12/10/2014
$8,000,000
Novaerus
11/20/2014
$10,000,000
Blueprint Medicines
11/14/2014
$50,000,000
Unum Therapeutics
10/22/2014
$12,000,000
Avidity Biosciences
10/8/2014
$6,000,000
Aclaris Therapeutics
10/2/2014
$21,000,000
Dimension Therapeutics
6/23/2014
$30,000,000
Coherus BioSciences
5/19/2014
$55,000,000
Blueprint Medicines
1/7/2014
$25,000,000
ReGen Biologics
12/31/2013
$7,892,000
Dimension Therapeutics
12/31/2013
$5,000,000
ViewRay
12/17/2013
$30,000,000
Symbiomix Therapeutics
6/30/2013
Unknown
Amphora Medical
6/30/2013
$6,000,000
Iora Health
4/16/2013
$14,000,000
Fluidnet
3/31/2013
Unknown
Kyruus
1/2/2013
$11,000,000
ViewRay
12/31/2012
$5,872,000
Ultragenyx Pharmaceutical
12/20/2012
$75,000,000
Aclaris Therapeutics
10/25/2012
$21,000,000
Ultragenyx Pharmaceutical
9/30/2012
$15,100,000
Lumere
8/4/2012
$1,100,000
Mersana Therapeutics
7/31/2012
$27,000,000
Liazon
4/24/2012
$18,200,000
Blueprint Medicines
3/31/2012
$5,999,000
ViewRay
3/13/2012
$45,000,000
Iora Health
12/31/2011
$6,250,000
NeuroTherapeutics Pharma
12/31/2011
$12,000,200
Imagen Biotech
10/19/2011
$40,000,000
Fluidnet
8/16/2011
$25,000,000
Proteostasis Therapeutics
6/30/2011
$25,623,000
Ultragenyx Pharmaceutical
6/20/2011
$45,000,000
Proteostasis Therapeutics
12/31/2010
$23,000,000
ViewRay
8/25/2010
$20,000,000
Accuri Cytometers
7/12/2010
$6,000,000
Vicept Therapeutics
6/30/2010
$10,000,000
FoldRx Pharmaceuticals
6/15/2010
$29,000,000
TetraPhase Pharmaceuticals
6/1/2010
$45,000,000
NeuroTherapeutics Pharma
5/20/2010
$43,000,000
Vicept Therapeutics
9/30/2009
$6,000,000
LigoCyte Pharmaceuticals
9/30/2009
$14,530,000
Accuri Cytometers
7/13/2009
$4,000,000
Proteostasis Therapeutics
6/30/2009
$7,556,000
NextWave Pharmaceuticals
6/30/2009
$6,917,000
ViewRay
12/31/2008
$15,000,000
EnVivo Pharmaceuticals
10/31/2008
$65,000,000
Mersana Therapeutics
10/24/2008
$4,000,000
Ironwood Pharmaceuticals
10/2/2008
$50,000,000
Proteostasis Therapeutics
8/25/2008
$45,000,000
Ikano Therapeutics
6/30/2008
$9,000,000
LigoCyte Pharmaceuticals
3/18/2008
$28,000,000
ViewRay
1/22/2008
$25,000,000
Transave
12/31/2007
$15,500,000
Topaz Pharmaceuticals
12/4/2007
$20,000,000
Ikano Therapeutics
6/30/2007
$4,200,000
Transave
6/30/2007
$2,684,000
Mersana Therapeutics
6/30/2007
$10,000,000
Bioconnect Systems
4/6/2007
$8,000,000
Ikano Therapeutics
3/31/2007
$3,000,000
FoldRx Pharmaceuticals
3/31/2007
$32,251,300
TetraPhase Pharmaceuticals
11/27/2006
$25,000,000
EnVivo Pharmaceuticals
10/4/2006
$24,000,000
Ikano Therapeutics
8/15/2006
$39,100,000
FoldRx Pharmaceuticals
5/31/2006
$43,000,000
Cardiokine
5/1/2006
$50,000,000
Transave
3/31/2006
$17,824,000
Microbia PE
2/27/2006
$75,000,000
Mersana Therapeutics
11/9/2005
$21,000,000
FoldRx Pharmaceuticals
12/13/2004
$16,000,000
EnVivo Pharmaceuticals
11/9/2004
$23,000,000

 

Investor Contacts

Title
Name
Email & Social
Partner
Benjamin Auspitz
  Benjamin Auspitz LinkedIn Profile  Benjamin Auspitz Twitter Account  Benjamin Auspitz News  Benjamin Auspitz on Facebook
Partner
Shervin Ghaemmaghami
  Shervin Ghaemmaghami LinkedIn Profile  Shervin Ghaemmaghami Twitter Account  Shervin Ghaemmaghami News  Shervin Ghaemmaghami on Facebook
Managing Partner
Stephen Knight
  Stephen Knight LinkedIn Profile  Stephen Knight Twitter Account  Stephen Knight News  Stephen Knight on Facebook
Partner
Benjamin Malka
  Benjamin Malka LinkedIn Profile  Benjamin Malka Twitter Account  Benjamin Malka News  Benjamin Malka on Facebook
Partner
Ketan Patel
  Ketan Patel LinkedIn Profile  Ketan Patel Twitter Account  Ketan Patel News  Ketan Patel on Facebook
Partner
Robert Weisskoff
  Robert Weisskoff LinkedIn Profile  Robert Weisskoff Twitter Account  Robert Weisskoff News  Robert Weisskoff on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

F-Prime Capital has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
1upHealth
ABK Biomedical
Accuri Cytometers
Aclaris Therapeutics
Adagene
Adela
Affinia Therapeutics
Akriveia Therapeutics
Albert Invent
Amphora Medical
AmplifyMD
Apellis Pharmaceuticals
AppliedVR
Argyle
ARTBIO
Artemis Health
Ashby
Atalanta Therapeutics
Avalyn Pharma
AvantStay
Avidity Biosciences
Axoni
Beam Therapeutics
Benchling
BenchSci
Better Life Partners
Bicara Therapeutics
Bioconnect Systems
blispay
Blueprint Medicines
Buoy Health
Burro
Cadence Neuroscience
Canary Technologies
Canoe Intelligence
Cardiokine
CareStack
Caribou Biosciences
Carrot Fertility
Castle Security
Castor Research
Centivo
Charm Therapeutics
Checkmate Pharmaceuticals
Coherus BioSciences
Compass Therapeutics
ConnexPay
Deal Engine
Denali Therapeutics
Devoted Health
Dimension Therapeutics
Doceree
Eleos Health
Elucidata
Embark Veterinary
Engrail Therapeutics
Ensoma
EnVivo Pharmaceuticals
Equip
EVEN Financial
Expressable
Firefly Health
Fluidnet
Flywire
FoldRx Pharmaceuticals
Funnel AB
Genoa Pharmaceuticals
HiLabs
Hone
Hurdle
Ikano Therapeutics
Imagen Biotech
Innovusion
InSilico Medicine
Invetx
Iora Health
Iowa Approach
Ironwood Pharmaceuticals
K36 Therapeutics
Kyruus
Latchel
Leyden Labs
Liazon
LigoCyte Pharmaceuticals
Logixboard
Lumere
LunaPBC
Mathison
Menlo Therapeutics
Mersana Therapeutics
Microbia PE
Modis Therapeutics
MoEngage
Nebula Genomics
Neumora Therapeutics
NeuroTherapeutics Pharma
NextWave Pharmaceuticals
NFlection Therapeutics
nOCD
Nocion Therapeutics
Notabene
Notable Health
Novaerus
Odaseva
OneAdvisory
OTA Insight
OWKIN
Papaya Payments
Paradigm
Parrot
PatientPing
PAX Labs
Peptone
Precision BioSciences
Prime Medicine
Promentis Pharmaceuticals
Protenus
Proteostasis Therapeutics
Proximie
Pulmocide
Quartet
Quovo
Rallybio
RareCyte
Recurly
ReGen Biologics
REGENXBIO
Rialtic
RightHand Robotics
Rippl Care
RiskLens
RiskRecon
Sana Biotechnology
Semma Therapeutics
Shinobi Therapeutics
Silq
Simon Data
Sironax
Snapdocs
Snapsheet
SonderMind
SpectrumAi
Stride Health
Surface Oncology
Symbiomix Therapeutics
T-Therapeutics
TandemAI
Teleo
Tempest Therapeutics
Tenpoint Therapeutics
TetraPhase Pharmaceuticals
Threat Stack
Toku
Topaz Pharmaceuticals
TraceLink
Tradier
Transave
Turnstone Biologics
Ultragenyx Pharmaceutical
Unison Home Ownership Investors
Unum Therapeutics
US HealthVest
Vendr
Verve Therapeutics
Vestwell
Vicept Therapeutics
ViewRay
VitalWare
WelbeHealth
Wellframe
Whatfix
Xilio Therapeutics
Zenflow
Zus Health

 

 

 

 

Browse more venture capital investors:

F-LOG Ventures | f.actor

 

Share this article

 

About Our VC Investors Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.